Priority Date: 12.08.11 (EP 20110006650)

NOVEL COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

  • Application ID: EP12756389
  • Status: GRANT OF PATENT INTENDED

Attorney

Company dna schiweck weinzierl koch gbr
no operation time available
Headquarter in München
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 12.08.2011 - Priority Date (EP 20110006650)
  • 21.02.2013 - Publication A1 (WO2013023982)
  • 18.06.2014 - Publication A1 (EP2742137)

IPC Classification